Dompé is an Italian biopharmaceutical company that focuses on innovation and research and development to meet the needs of neglected therapeutic areas and rare diseases.
Dompé was established in 1940 in Milan where the company continues to have its headquarters. In Italy, it also has an industrial and biotech research hub in offices in L’Aquila and an R&D division in Naples.
Dompé also has branches in Barcelona, Berlin, Paris, and Tirana and also in Boston and San Francisco in the US.
Dompé’s Chief Operating Officer, Eriona Gjinukaj, responsible for creating the Italian mid-cap’s US affiliate, reveals the challenges and rewards of that experience and explains how she saw the company go…
Eugenio Aringhieri discusses Dompé’s shift in strategy towards opthalmology, instilling an innovation mindset, and broadening the company’s international horizons. Since we last interviewed you in 2009 a lot has happened:…
You recently declared that in a context of new emerging challenges for pharmaceutical companies, those who would survive would not be the strongest ones but the most responsive to change.…
Dompé’s Chief Operating Officer, Eriona Gjinukaj, responsible for creating the Italian mid-cap’s US affiliate, reveals the challenges and rewards of that experience and explains how she saw the company go…
Eugenio Aringhieri discusses Dompé’s shift in strategy towards opthalmology, instilling an innovation mindset, and broadening the company’s international horizons. Since we last interviewed you in 2009 a lot has happened:…
You recently declared that in a context of new emerging challenges for pharmaceutical companies, those who would survive would not be the strongest ones but the most responsive to change.…
See our Cookie Privacy Policy Here
